Radiation boost may supercharge CAR T-Cell therapy against tough lymphoma
Disease control
Not yet recruiting
This trial tests whether adding low-dose total body irradiation (TBI) to standard chemotherapy before CAR T-cell therapy (tisagenlecleucel) is safe and effective for adults with large B-cell lymphoma that has returned or not responded to prior treatments. The study involves 18 pa…
Phase: PHASE1 • Sponsor: Nathan Denlinger • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC